Viemed Healthcare IncVMD
Price$9.10Intrinsic value$12.3436% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $12.34median of 6 methods · middle span $10-$18based on filings through 30 Jun 2026
Market Price $9.10Price as of 30 Sep 2026
Margin of Safety +35.6%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 33.9% (near-term consensus, capped) · years 2–5: 20.5%/yr (balance of the path).23.1% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 617.7%Yr 714.9%Yr 812.0%Yr 99.2%Yr 106.4%
20.5% → 6.4%
Years 11–20: glide to long-run rate
Per-year rates
Yr 116.0%Yr 125.7%Yr 135.4%Yr 145.0%Yr 154.7%Yr 164.4%Yr 174.0%Yr 183.7%Yr 193.3%Yr 203.0%
6.4% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)6.4%
Discount rate (cost of equity) 9.8%
Volatility vs market (adjusted beta)1.08

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetViemed Healthcare IncVMDHealth Care
Valuation
P/E25.3×
P/S1.1×
P/B2.5×
EV / Revenue1.1×
EV / EBITDA7.7×
Profitability
Gross margin56.8%
Operating margin5.7%
Net margin4.8%
FCF margin9.7%
Returns
ROE10.1%
ROA7.1%
ROIC10.3%
Growth
Revenue growth (YoY)34.5%
5-yr fwd EPS growth23.1%
Financial strength
Debt / Equity0.05×
Current ratio1.13×
Altman Z-Score6.1
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.